Dong Hui Yang
Gründer bei Hangzhou Adlai Nortye Biopharma Co. Ltd.
Aktive Positionen von Dong Hui Yang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Direktor/Vorstandsmitglied | - | - |
| Gründer | 01.01.2004 | - | |
| Corporate Officer/Principal | - | - |
Karriereverlauf von Dong Hui Yang
Ehemalige bekannte Positionen von Dong Hui Yang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADLAI NORTYE LTD. | Direktor/Vorstandsmitglied | 01.06.2018 | - |
| Corporate Officer/Principal | - | - |
Ausbildung von Dong Hui Yang
| Jiangxi Normal University | Undergraduate Degree |
| South China Normal University | Graduate Degree |
Statistik
International
| China | 4 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
- Börse
- Insiders
- Dong Hui Yang
- Erfahrung
